打印 来自妙佑医疗国际员工 申请预约 关于 March 31, 2022 打印 显示参考文献 CA-125. Testing.com. https://www.testing.com/tests/ca-125/. Accessed Dec. 14, 2021. CA 125 levels: Your guide. Foundation for Women's Cancer. https://www.foundationforwomenscancer.org/gynecologic-cancers/cancer-types/ovarian/. Accessed Dec. 17, 2021. Tumor markers. National Cancer Institute. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet. Accessed Dec. 14, 2021. Cancer antigen 125 (CA 125), serum. Mayo Clinical Laboratories. https://www.mayocliniclabs.com/test-catalog/overview/9289#Clinical-and-Interpretive. Accessed Dec. 14, 2021. Ovarian, fallopian tube, and primary peritoneal cancer screening (PDQ) – Patient version. National Cancer Institute. https://www.cancer.gov/types/ovarian/patient/ovarian-screening-pdq#section/all. Accessed Dec. 14, 2021. Zhang M, et al. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. BBA – Reviews on Cancer. 2021; doi:10.1016/j.bbcan.2021.188503. Duska LR. Approach to survivors of epithelial ovarian, fallopian tubal, or peritoneal carcinoma. https://www.uptodate.com/contents/search. Accessed Dec. 14, 2021. Genetic/familial high-risk assessment: Breast and ovarian. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1503. Accessed Sept. 7, 2021. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1453. Accessed Sept. 7, 2021. AskMayoExpert. Screening and risk reduction for ovarian cancer. Mayo Clinic; 2021. 相关 卵巢囊肿 卵巢癌 产品与服务 书籍:《妙佑医疗国际家庭健康手册》第 5 版 妙佑医疗国际综合癌症中心 简报:妙佑医疗国际卫生来信 — 数字版 显示更多来自妙佑医疗国际的产品和服务 妙佑医疗国际明尼苏达州罗切斯特院区和亚利桑那州凤凰城/斯科茨代尔院区均被《美国新闻与世界报道》评为 2022-2023 全美顶尖癌症医院。 了解更多关于这一最高荣誉的信息 CA 125 检测关于 PRC-20393282 患者护理和健康信息 医学检查与医疗程序 CA 125 检测